The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of the Company has on 25 February 2022 entered into a Memorandum of Understanding (“MOU”) with Bionet Asia Co. Ltd. to establish the framework for parties to exchange information and know-how, in order to facilitate registration, manufacture, supply and market various finished products, as well as bulk antigens in respect of biopharmaceuticals products particularly vaccines.

Please refer to the attachment for details of the announcement.

This announcement is dated 25 February 2022.